An open-label phase I dose-finding study of APR-246 in hematological malignancies
Stefan Deneberg(Karolinska University Hospital), Sören Lehmann(Uppsala University), Honar Cherif(National Center for Cancer Care and Research), Gunnar Juliusson(Lund University), Mia von Euler(University Hospital of North Norway), Vladimir Lazarević(Skåne University Hospital), P-O Andersson(Södra Älvsborg Hospital)
Cited by 85
Related Papers
Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
|New England Journal of Medicine|2014|3.5k
Anastrozole Is Superior to Tamoxifen as First-Line Therapy for Advanced Breast Cancer in Postmenopausal Women: Results of a North American Multicenter Randomized Trial
|Journal of Clinical Oncology|2000|996
Anastrozole Versus Tamoxifen as First-Line Therapy for Advanced Breast Cancer in 668 Postmenopausal Women: Results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability Study
|Journal of Clinical Oncology|2000|840
Reappearance of Hippocampal CA1 Neurons after Ischemia is Associated with Recovery of Learning and Memory
|Journal of Cerebral Blood Flow & Metabolism|2005|169